logo-loader
viewInnovaDerma PLC

InnovaDerma PLC - Director/PDMR Shareholding

RNS Number : 2004V
InnovaDerma PLC
29 November 2019
 

  LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Company")

 Director/PDMR shareholding

InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, announces that it was notified today, that Joseph Bayer, Executive Chairman of the Company, has purchased 3,000 Ordinary Shares of €0.10 each in the Company at a price of 62.00 pence per Ordinary Share (the "Acquisition") which will be held via his Australian Superannuation Fund which Mr Bayer controls.  He now holds 129,000 Ordinary Shares in the Company via his Australian Superannuation Fund

Following the Acquisition, Joseph Bayer has, through direct and indirect holdings, a total interest in the Company of 161,840 Ordinary Shares representing approximately 1.12% of the issued share capital of the Company.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Further enquiries

InnovaDerma

Joe Bayer

Kieran Callan c/o TB Cardew

 

+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/ Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

[email protected]

 

 

 

 

1.               

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

 Joseph Bayer

 

2.               

Reason for the Notification

 

a)

Position/status

Executive Chairman

 

b)

Initial notification/Amendment

Initial notification

3.    

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

InnovaDerma PLC

 

b)

LEI

213800WRAP6W8VDL6B38

 

4.    

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the Financial instrument, type of instrument

€0.10 each ("Ordinary Shares")

Identification code

IDP         GB00BT9PTW34

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

Volume and Price -3,000 Ordinary Shares at 62 pence per share

 

d)

Aggregated information:

Aggregated volume

Price

 

See 4c) above

 

e)

Date of the transaction

29 November 2019

 

f)

Place of the transaction

London Stock Exchange, Main Market

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHUKUSRKOAAUAA

Quick facts: InnovaDerma PLC

Price: 40.875

Market: LSE
Market Cap: £5.93 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

InnovaDerma 'well-positioned' with a strong pipeline of new products and...

InnovaDerma PLC's (LON:IDP) Joe Bayer and Kieran Callan talk Proactive London's Andrew Scott through their half year report as well as updating on new products and plans. In its results statement covering the six months to the end of 2019, the developer of beauty, personal care and life...

on 27/2/20